{"id":"https://openalex.org/W3094209484","doi":"https://doi.org/10.1177/1078155220968615","title":"Brentuximab vedotin in real life, a seven year experience in patients with refractory/relapsed CD30+ T cell lymphoma","display_name":"Brentuximab vedotin in real life, a seven year experience in patients with refractory/relapsed CD30+ T cell lymphoma","publication_year":2020,"publication_date":"2020-10-25","ids":{"openalex":"https://openalex.org/W3094209484","doi":"https://doi.org/10.1177/1078155220968615","mag":"3094209484","pmid":"https://pubmed.ncbi.nlm.nih.gov/33100177"},"language":"en","primary_location":{"id":"doi:10.1177/1078155220968615","doi":"https://doi.org/10.1177/1078155220968615","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1078155220968615","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009487344","display_name":"Lucie Ob\u00e9ric","orcid":"https://orcid.org/0000-0002-0039-1983","observed_orcids":["https://orcid.org/0000-0002-0039-1983"]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lucie Oberic","raw_affiliation_strings":["Department of Haematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I3019448017","https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031377546","display_name":"Faustine Delzor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Faustine Delzor","raw_affiliation_strings":["Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, University Hospital Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, University Hospital Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I3019448017","https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047380983","display_name":"Caroline A. Protin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Caroline Protin","raw_affiliation_strings":["Department of Haematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I3019448017","https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049212934","display_name":"Sophie Perriat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sophie Perriat","raw_affiliation_strings":["Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, University Hospital Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, University Hospital Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I3019448017","https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085149424","display_name":"Camille Laurent","orcid":"https://orcid.org/0000-0002-5375-7512","observed_orcids":["https://orcid.org/0000-0002-5375-7512"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4210087620","display_name":"Centre de Recherches en Canc\u00e9rologie de Toulouse","ror":"https://ror.org/003412r28","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210087620","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4405258862","display_name":"Universit\u00e9 de Toulouse","ror":"https://ror.org/01ahyrz84","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Camille Laurent","raw_affiliation_strings":["Centre de Recherches en Canc\u00e9rologie de Toulouse (CRCT), Team 9, INSERM UMR1037, Universit\u00e9 de Toulouse, Toulouse, France","Department of Pathology, IUCT-Oncopole, CHU Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Recherches en Canc\u00e9rologie de Toulouse (CRCT), Team 9, INSERM UMR1037, Universit\u00e9 de Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210087620","https://openalex.org/I4405258862"]},{"raw_affiliation_string":"Department of Pathology, IUCT-Oncopole, CHU Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I3019448017","https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027272660","display_name":"Ana\u00efs Grand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ana\u00efs Grand","raw_affiliation_strings":["Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, University Hospital Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, University Hospital Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I3019448017","https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111422691","display_name":"Jean Marie Canonge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean Marie Canonge","raw_affiliation_strings":["Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, University Hospital Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, University Hospital Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I3019448017","https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006217162","display_name":"C\u00e9cile Borel","orcid":"https://orcid.org/0000-0002-0270-9772","observed_orcids":["https://orcid.org/0000-0002-0270-9772"]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C\u00e9cile Borel","raw_affiliation_strings":["Department of Haematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I3019448017","https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012997824","display_name":"Martin Gauthier","orcid":"https://orcid.org/0000-0001-5338-2071","observed_orcids":["https://orcid.org/0000-0001-5338-2071"]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Martin Gauthier","raw_affiliation_strings":["Department of Haematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I3019448017","https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013649293","display_name":"Lo\u00efc Ysebaert","orcid":"https://orcid.org/0000-0003-4102-7261","observed_orcids":["https://orcid.org/0000-0003-4102-7261","https://orcid.org/0000-0001-8478-5623"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4210087620","display_name":"Centre de Recherches en Canc\u00e9rologie de Toulouse","ror":"https://ror.org/003412r28","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210087620","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4405258862","display_name":"Universit\u00e9 de Toulouse","ror":"https://ror.org/01ahyrz84","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lo\u00efc Ysebaert","raw_affiliation_strings":["Centre de Recherches en Canc\u00e9rologie de Toulouse (CRCT), Team 9, INSERM UMR1037, Universit\u00e9 de Toulouse, Toulouse, France","Department of Haematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Recherches en Canc\u00e9rologie de Toulouse (CRCT), Team 9, INSERM UMR1037, Universit\u00e9 de Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210087620","https://openalex.org/I4405258862"]},{"raw_affiliation_string":"Department of Haematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I3019448017","https://openalex.org/I4210098740"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017026685","display_name":"Florent Puisset","orcid":"https://orcid.org/0000-0002-3083-5784","observed_orcids":["https://orcid.org/0000-0002-3083-5784"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210087620","display_name":"Centre de Recherches en Canc\u00e9rologie de Toulouse","ror":"https://ror.org/003412r28","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210087620","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4405258862","display_name":"Universit\u00e9 de Toulouse","ror":"https://ror.org/01ahyrz84","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Florent Puisset","raw_affiliation_strings":["Centre de Recherches en Canc\u00e9rologie de Toulouse (CRCT), Team 14, INSERM UMR1037, Universit\u00e9 de Toulouse, Toulouse, France","Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, Toulouse, France"],"raw_orcid":"https://orcid.org/0000-0002-3083-5784","affiliations":[{"raw_affiliation_string":"Centre de Recherches en Canc\u00e9rologie de Toulouse (CRCT), Team 14, INSERM UMR1037, Universit\u00e9 de Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210087620","https://openalex.org/I4405258862"]},{"raw_affiliation_string":"Pharmacy Department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, Toulouse, France","institution_ids":["https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5017026685"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210087620","https://openalex.org/I4210098740","https://openalex.org/I4210128666","https://openalex.org/I4405258862"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":1.299,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.80340448,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"27","issue":"7","first_page":"1730","last_page":"1735"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brentuximab-vedotin","display_name":"brentuximab vedotin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cd30-lymphoma","display_name":"CD30+ lymphoma","score":0.8679999709129333},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7979999780654907},{"id":"https://openalex.org/keywords/complete-response-rate","display_name":"complete response rate","score":0.9449999928474426},{"id":"https://openalex.org/keywords/stem-cell-transplantation","display_name":"stem cell transplantation","score":0.8119999766349792},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9340000152587891},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9639999866485596},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8080000281333923},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.8690000176429749}],"concepts":[{"id":"https://openalex.org/C2778191690","wikidata":"https://www.wikidata.org/wiki/Q422324","display_name":"Brentuximab vedotin","level":4,"score":0.9630788564682007},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9315550327301025},{"id":"https://openalex.org/C2777872185","wikidata":"https://www.wikidata.org/wiki/Q486090","display_name":"Anaplastic large-cell lymphoma","level":3,"score":0.7517691850662231},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7075517177581787},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6011232733726501},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5880329608917236},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5594412088394165},{"id":"https://openalex.org/C2777891184","wikidata":"https://www.wikidata.org/wiki/Q7168693","display_name":"Peripheral T-cell lymphoma","level":4,"score":0.5573818683624268},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.555793821811676},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5078848004341125},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.49271419644355774},{"id":"https://openalex.org/C70905583","wikidata":"https://www.wikidata.org/wiki/Q3648608","display_name":"CD30","level":3,"score":0.4619247317314148},{"id":"https://openalex.org/C2779050716","wikidata":"https://www.wikidata.org/wiki/Q4826373","display_name":"Autologous stem-cell transplantation","level":3,"score":0.44569918513298035},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3392564058303833},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.21702927350997925},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17273259162902832},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.07003134489059448},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000079963","descriptor_name":"Brentuximab Vedotin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016411","descriptor_name":"Lymphoma, T-Cell, Peripheral","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017730","descriptor_name":"Ki-1 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1177/1078155220968615","doi":"https://doi.org/10.1177/1078155220968615","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1078155220968615","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},{"id":"pmid:33100177","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33100177","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-04920640v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-04920640","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Oncology Pharmacy Practice, 2020, 27 (7), pp.1730-1735. ⟨10.1177/1078155220968615⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W2032713012","https://openalex.org/W2139891818","https://openalex.org/W2149005508","https://openalex.org/W2155256323","https://openalex.org/W2156506990","https://openalex.org/W2324143682","https://openalex.org/W2336054546","https://openalex.org/W2416844197","https://openalex.org/W2500482667","https://openalex.org/W2560792339","https://openalex.org/W2795353272","https://openalex.org/W2803000479","https://openalex.org/W2884872485","https://openalex.org/W2903308035","https://openalex.org/W2923108569","https://openalex.org/W3005099450"],"related_works":["https://openalex.org/W2298630424","https://openalex.org/W3094834216","https://openalex.org/W3094835741","https://openalex.org/W3005099450","https://openalex.org/W2397014812","https://openalex.org/W4412934771","https://openalex.org/W2899907622","https://openalex.org/W4310107674","https://openalex.org/W4402897807","https://openalex.org/W3212235693"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Brentuximab":[1],"vedotin":[2],"(Bv)":[3],"has":[4],"been":[5],"approved":[6],"for":[7],"the":[8,33,87],"treatment":[9],"of":[10,35,63,122,171],"Refractory/Relapsed":[11],"(R/R)":[12],"Anaplastic":[13],"Large":[14],"Cell":[15,42,128],"Lymphomas":[16],"(ALCL)":[17],"and":[18,135,142,162],"cutaneous":[19],"T-Cell":[20],"Lymphomas,":[21],"but":[22],"is":[23],"also":[24],"effective":[25],"in":[26,48,74,93,154,166,174],"other":[27],"CD30+":[28],"malignancies.":[29],"We":[30],"report":[31],"here":[32],"outcomes":[34],"patients":[36,64,81,124],"with":[37,46,65,70,76,83,156],"various":[38],"R/R":[39,66,167],"Peripheral":[40],"T":[41],"Lymphoma":[43],"(PTCL)":[44],"treated":[45,68,82],"Bv":[47,71,96,114,152,172],"real":[49],"life":[50],"practice.":[51],"METHOD:":[52],"This":[53],"was":[54,86,97,107,110,115],"a":[55,159],"retrospective,":[56],"single-center":[57],"study":[58,149],"based":[59],"on":[60],"medical":[61],"records":[62],"PTCL":[67],"either":[69],"alone":[72],"or":[73],"combination":[75,100,118,155],"chemotherapy.":[77],"RESULTS:":[78],"Among":[79],"27":[80],"Bv,":[84],"neutropenia":[85],"main":[88],"serious":[89],"adverse":[90],"event":[91],"observed":[92],"particular":[94],"when":[95,113],"used":[98,116,153],"as":[99,117],"treatment.":[101,119],"The":[102,120,169],"complete":[103],"Response":[104],"Rates":[105],"(CRR)":[106],"40.7%;":[108],"it":[109],"significantly":[111],"improved":[112],"majority":[121],"eligible":[123],"(7/10)":[125],"underwent":[126],"Stem":[127],"Transplantation.":[129],"Median":[130],"Progression":[131],"Free":[132],"Survival":[133,137],"(PFS)":[134],"Overall":[136],"(OS)":[138],"were":[139],"5.2":[140],"months":[141,144],"12.5":[143],"respectively.":[145],"CONCLUSION:":[146],"Our":[147],"current":[148],"shows":[150],"that":[151],"chemotherapy":[157],"provides":[158],"high":[160],"CRR":[161],"thereby":[163],"allows":[164],"SCT":[165],"PTCL.":[168],"use":[170],"treatments":[173],"this":[175],"setting":[176],"warrants":[177],"further":[178],"investigation.":[179]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-10-29T00:00:00"}